T

Theravance Biopharma
D

TBPH

11.110
USD
0.06
(0.54%)
مغلق
حجم التداول
2,152
الربح لكل سهم
0
العائد الربحي
-
P/E
-9
حجم السوق
555,514,799
أصول ذات صلة
A
AGIO
0.645
(1.82%)
36.020 USD
A
ARRY
0.80000
(11.51%)
7.75000 USD
B
BHVN
-0.170
(-1.15%)
14.580 USD
E
ESPR
0.02000
(1.74%)
1.17000 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
X
XNCR
0.09500
(1.14%)
8.40000 USD
المزيد
الأخبار المقالات

العنوان: Theravance Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).